Back to Journals » Journal of Hepatocellular Carcinoma » Volume 4

Open-label phase II clinical trial in 75 patients with advanced hepatocellular carcinoma receiving daily dose of tableted liver cancer vaccine, hepcortespenlisimut-L

Total article views   Abstract views HTML views PDF downloads Totals
7,206 Dovepress* 4,721 1,534+ 491 6,255
PubMed Central* 0 951 139 951
Totals 4,721 2,485 630 7,206
*Since 12 April 2017
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
210 0 0 0 2 208

View citations on PubMed Central and Google Scholar